AC Immune (ACIU) Short Interest Ratio & Short Volume

Short interest is the volume of AC Immune shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 506,200 shares of ACIU short. 0.88% of AC Immune's shares are currently sold short. Learn More on AC Immune's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACIU shares currently have a short interest ratio of 3.0. Learn More on AC Immune's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AC Immune: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.88% of AC Immune's floating shares are currently sold short.

AC Immune saw a decrease in short interest in April. As of April 30th, there was short interest totaling 506,200 shares, a decrease of 0.6% from the previous total of 509,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

AC Immune currently has issued a total of 98,900,000 shares. Some of AC Immune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AC Immune currently has a public float of 57,660,000 shares.

0.88% of AC Immune's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AC Immune: Conduit Pharmaceuticals Inc. (0.42%), Veru Inc. (8.35%), Foghorn Therapeutics Inc. (7.05%), Emergent BioSolutions Inc. (14.13%), uniQure (6.72%), 23andMe Holding Co. (12.81%), Puma Biotechnology, Inc. (8.96%), Zevra Therapeutics, Inc. (6.15%), Aldeyra Therapeutics, Inc (4.03%), Werewolf Therapeutics, Inc. (1.39%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling ACIU is an investing strategy that aims to generate trading profit from AC Immune as its price is falling. ACIU shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AC Immune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACIU, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACIU, twice per month. The most recent reporting period available is April, 30 2024.